PET analysis of human dopamine receptor subtypes using 11C-SCH 23390 and 11C-raclopride

Psychopharmacology

Volumn 92, Issue 3, 1987, Pages 278-284

  Farde, L ^a   Halldin, C ^a   Stone Elander, S ^a   Sedvall, G ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Antipsychotic drug treatment; Dopamine receptor subtypes; Positron emission tomography; Raclopride; SCH 23390

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE C 11; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; FLUPENTIXOL DECANOATE; RACLOPRIDE; RACLOPRIDE C 11; RADIOISOTOPE; SULPIRIDE; UNCLASSIFIED DRUG;

BRAIN; CENTRAL NERVOUS SYSTEM; COMPUTER ANALYSIS; DIAGNOSIS; DRUG ACCUMULATION; DRUG COMPARISON; DRUG DISTRIBUTION; DRUG INTERACTION; DRUG RECEPTOR BINDING; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PATIENT; PHARMACOKINETICS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; SCHIZOPHRENIA; THERAPY; VOLUNTEER;

ADULT; BENZAZEPINES; BRAIN; CARBON RADIOISOTOPES; FLUPENTHIXOL; HUMAN; MALE; MIDDLE AGE; RACLOPRIDE; RECEPTORS, DOPAMINE; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; SALICYLAMIDES; SCH-23390; SCHIZOPHRENIA; SULPIRIDE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0023188902     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/BF00210831     Document Type: Article

References (38)

1. Postmortem distribution of dopamine and homovanillic acid in human brain, variations related to age, and a review of the literature
2. Specific binding of 3H-SCH 23390 to dopamine D1 receptors in vivo
3. Differential involvement of dopamine D-1 and D-2 receptors in the circling behaviour induced by apomorphine, pergolide and LY171555 in 6-hydroxydopamine-lesioned rats
4. Head fixation device for reproducible positron alignment in transmission CT and positron emission tomography
5. Characterization of the binding of 3H-SCH 23390, a selective D-1-receptor antagonist ligand, in rat striatum
6. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs
7. The classification of dopamine receptors: relationship to radioligand binding
8. 3H-Flupentixol binding in post-mortem brains of schizophrenics: evidence for a selective increase in dopamine D2 receptors
9. D-1 dopamine receptors in the rat brain: autoradiographic localization using 3H-SCH 23390
10. Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography
11. Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET
12. Comparisons between the in vitro binding of two substituted benzamides and two butyrophenones to dopamine-D2 receptors in the rat striatum
13. Some in vitro receptor binding properties of 3H-Eticlopride, a novel substituted benzamide, selective for dopamine-D2 receptors in the rat brain
14. Preparation of 11C-labelled SCH 23390 for the in vivo study of dopamine D1 receptors using positron emission tomography
15. Effect of the dopamine D-1 antagonist SCH 23390 on rotational behaviour induced by apomorphine and pergolide in 6-hydroxy-dopamine denervated rats
16. SCH 23390 — the first selective dopamine D1 antagonist
17. Biochemical and pharmacological differentiation of neuroleptic effect on dopamine D1 and D2 receptors
18. SCH 23390. A benzazepine with atypical effects on dopaminergic systems
19. Interaction of substituted benzamide drugs with cerebral dopamine receptors
20. A sensitive and specific radioimmunoassay for cis(Z)-flupentixol in human serum
21. Serum concentrations of cis(Z)-flupentixol and prolactin in chronic schizophrenic patients treated with flupentixol and cis(Z)-flupentixol decanoate
22. Multiple receptors for dopamine
23. Dopamine sensitive adenylate cyclase in the caudate nucleus of rat brain, and its similarity to the “dopamine receptor”
24. Autoradiographic visualization of dopamine D2 receptors in the monkey brain using the selective benzamide drug 3H-raclopride
25. Specific in vitro and in vivo binding of 3H-raclopride
26. Potential neuroleptic agents. 4. Chemistry, behavioural pharmacology and blocking of 3H-spiperone binding of 3,5-disubstituted N-[(1-ethyl-2-pyrrolidinyl)methyl]-6-methoxysalicylamides
27. Relationship of neuroleptic drug effects at brain dopamine, serotonin, adrenergic and histamine receptors to clinical potency
28. 3H-SCH 23390 labelled D1 dopamine receptors are unchanged in schizophrenia and parkinsons disease
29. Binding of 3H-SCH 23390 to D1 receptors in the putamen of control and parkinsonian subjects
30. 3H-SCH 23390 has the characteristics of a dopamine receptor ligand in the rat central nervous system
31. Imaging of neurotransmitter receptors in the living human brain
32. Dopamine D1-receptor binding in the living human brain
33. Antipsychotic drug doses and neuroleptic/dopamine receptors
34. Bimodal distribution of dopamine receptor densities in brain of schizophrenics
35. Topographical distribution of dopaminergic innervation and dopaminergic receptors of the anterior cerebral cortex of the rat
36. Multiple dopamine receptors
37. Imaging dopamine receptors in the human brain by positron emission tomography